Ukwelashwa Sula Cell Renal Cell Carcinoma

Ukwelashwa kwe-Clear Renal Renal Cell Carcinoma: Izinketho eziningi zezifundo zokwelapha ezicacile ze-Recal Renal Cell Carcinoma (CCRCC) zibalulekile ezigulini nasemindenini yazo. Lo mhlahlandlela uhlinzeka ngesibukezo esinemininingwane yezindlela zokwelashwa zamanje, ezigxile emikhubeni esekwe kobufakazi kanye nokunakekelwa okugxile kweziguli. Sizohlola izigaba ezahlukahlukene ze-CCRCC kanye nezokwelapha ezihlanganisiwe esigabeni ngasinye, zigqamisa ukubaluleka kokuxilongwa kusenesikhathi kanye nokuphathwa okusebenzayo. Lolu lwazi lwenzelwe izinjongo zokufundisa futhi akufanele lubhekwe njengeluleke lwezokwelapha. Hlala uthintana nochwepheshe wakho wezokunakekelwa kwempilo ezinhlelweni zokwelashwa ezenzelwe wena.

Ukuxilongwa kanye nokuhlanza i-CCRCC

Ukuxilongwa okunembile kanye nokuzihlamba kubaluleke kakhulu ekunqumeni isu elisebenzayo lokwelashwa elisebenzayo Sula Cell Renal Cell Carcinoma. Amasu wokulingisa, njenge-CT Scans ne-MRI, kubalulekile ukukhomba usayizi, indawo, kanye nokusakazeka okungenzeka. Ama-biopsies ajwayele ukwenziwa ukuqinisekisa ukuxilonga futhi anqume uhlobo oluthile lomdlavuza wezinso, kufaka phakathi ubukhona be-CCRCC. Amasu wokugabha, njengohlelo lwesitayela se-TNM, ahlukanise ubukhulu bomdlavuza, onethonya izinqumo zokwelashwa. Ukutholwa kusenesikhathi, ngokuhlolwa okujwayelekile kanye nokuphenywa okusheshayo kwezimpawu, kuthuthukisa kakhulu ukufuthina.

Ukuqonda uhlelo lwe-TNM Stiluging

Uhlelo lwe-TNM Stiaging lusebenzisa izinto ezintathu ukuhlukanisa Sula Cell Renal Cell Carcinoma: T: Chaza usayizi nobungako bemifanekiso yokuqala. N: Ibonisa ukuzibandakanya kwezindawo eziseduze ze-lymph node. M: Icacisa ukuthi umdlavuza une-metastasised (Spread) ezinhlakeni ezikude kakhulu.Each kwalezi zinto zithola isiteji sezinombolo (e.g., T2, T2, njll.), Njll.), Njll.), Njll.), Njll.) Inhlanganisela ye-T, n, kanye nezigaba ze-M zinikezela ngesigaba sonke somdlavuza.

Izinketho zokwelashwa ze-CCRCC

Izinketho zokwelashwa ze Sula Cell Renal Cell Carcinoma hlukana ngokusekelwe esigabeni somdlavuza kanye nempilo yesiguli yonke. Ukuvuselelwa kokuhlinzwa kuvame ukwelashwa okuyinhloko kwe-CCRCC yasendaweni, kuyilapho izindlela zokwelapha ezihlelekile, kufaka phakathi ukwelashwa okuhlosiwe kanye ne-immunotherapy, zivame ukuqashwa ngenxa yesifo esithuthukile noma se-metastatic.

Okuhlinzayo okuhlinza

Okwenzelwe okwenziwe Sula Cell Renal Cell Carcinoma, Ukususa isimila kanye nengxenye engaba yingxenye noma yonke yezinso ezithintekile (i-nephrectomy engxenyenamba noma i-naphrectomy ye-radical) imvamisa ingumugqa wokuqala wokwelashwa. Ukuzikhethela phakathi kwalezi zinqubo kuya ngezinto eziningana, kufaka phakathi usayizi we-SUMOTE, indawo, kanye nempilo yesiguli. Amasu wokuhlanza kancane, njengokuhlinzwa kwe-laparoscopic, ayanda kakhulu, anciphise isikhathi sokutakula kanye nezinkinga ezingaba khona.

Ukwelashwa okuhlosiwe

Izindlela zokwelapha ezihlosiwe zisebenza ngokuvimbela ama-molecule athile anikela ekukhuleni kwezimila. Izindlela eziningi zokwelapha ezihlosiwe ziye zafakazela ukuthi Sula Cell Renal Cell Carcinoma, ikakhulukazi lezo ezibhekiswe yi-vascular endothelial Fight Fight (vegf) kanye nethagethi yesilwane sase-rabamycin (MTOR). Izibonelo zifaka iSunitinib, i-sorafenib, iPazopanib, ne-Enyeperimus. Le mithi ingahanjiswa ngomlomo futhi ivame ukusetshenziswa njengokwelashwa komugqa wokuqala noma komugqa wesibili we-metastatic CCRCC. Imiphumela emibi iyajwayelekile futhi ingahluka phakathi kwabantu. I-Oncologist yakho izokubheka ngokucophelela ngesikhathi sokwelashwa.

I-ImmunoSatherapy

I-ImmunoSatherapy ibeka amasosha omzimba uqobo okulwa namaseli womdlavuza. Ukuhlola inhibitors, njenge-nivolumab ne-ipilamab, block yokuhlola ukushisa komzimba, okuvumela amasosha omzimba aqaphele futhi ahlasele ama-cell cell ngokuphumelelayo. Le mithi isetshenziswa kaningi ku-Advanced noma MetaStatic Sula Cell Renal Cell Carcinoma futhi kungahlanganiswa nokwelashwa okuhlosiwe kwemiphumela ethuthukisiwe. I-ImmunoSatherapy ingakhiqiza imiphumela emibi ebalulekile, kufaka phakathi izinkinga ze-autoimmune, ezingadinga ukuphathwa kwezokwelapha okusondele.

Ukwelashwa kwemisebe

Ngenkathi kungenjalo ukwelashwa okuyisisekelo kwe-CCRCC, ukwelashwa kwemisebe kungadlala indima esekelayo ekuphatheni izinhlungu kuma-metastases amathambo noma ekwelapheni ukuphindela kabusha kwasendaweni ngemuva kokuhlinzwa.

Izilingo Zomtholampilo

Iziguli ezine Sula Cell Renal Cell Carcinoma kufanele acabangele ukubamba iqhaza ezivivinyweni zomtholampilo. Izilingo zemitholampilo zinikeza ukufinyelela ekwethembisa izindlela zokwelapha ezintsha futhi zinikele ekuthuthukisweni kocwaningo lomdlavuza. Udokotela wakho angakusiza ekutholeni amathuba emitholampilo afanelekile. I-Shandong Bandoong Baafa Cancer Research Institute https://www.baofahospital.com/ Kunikezelwe ekunikezeni ukunakekelwa komdlavuza okuthuthukile nokwenza ucwaningo olugxile ekuthuthukiseni imiphumela yeziguli.

Ukuqapha nokulandela

Ngemuva kokwelashwa, aphoyintimenti okulandela okujwayelekile kubalulekile ekuqapheleni kokuphindaphindwa noma ukuthuthukiswa kwama-tumors amasha. Izifundo zokucabanga kanye nokuhlolwa kwegazi kuvame ukusetshenziselwa ukuqapha ukuqhubeka kwezifo. Ukutholwa kusenesikhathi kwe-rectionlence kuvumela ukungenelela okusheshayo futhi kungathuthukisa imiphumela.

Uhlobo lokwelashwa	Umshini	Isigaba se-CCRCC	Imiphumela emibi ejwayelekile
Okuhlinzayo okuhlinza	Ukususwa ngokomzimba kwesimila	I-CCRCC yasendaweni	Ubuhlungu, ukutheleleka, ukopha
Ukwelashwa okuhlosiwe	Ukuvinjwa kwama-molecule athile	I-Metastatic CCRCC	Ukukhathala, isicanucanu, umfutho wegazi ophakeme
I-ImmunoSatherapy	Ukugqugquzela amasosha omzimba	I-Metastatic CCRCC	Ukukhathala, ukuqhekeka kwesikhumba, izinkinga ze-autoimmune

Ukuzikhulula: Lolu lwazi lwenzelwe izinjongo zokufundisa kuphela futhi akufanele lubhekwe njengeluleke lwezokwelapha. Hlala uthintana nomuntu oqeqeshiwe wezokunakekelwa kwezempilo ukuze kuxilongwa kanye nokwelashwa kwanoma yisiphi isimo sezokwelapha.